✦ LIBER ✦

Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation

✍ Scribed by Nina Singh; Timothy Gayowski; Oliver K. Ndimbie; Sayah Nedjar; Marilyn M. Wagener; Victor L. Yu

Book ID: 117220661
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 446 KB
Volume: 119
Category: Article
ISSN: 0039-6060
DOI: 10.1016/s0039-6060(96)80147-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early development of chronic active hepa

Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection

✍ Marina Berenguer; Martín Prieto; Juan Córdoba; José Miguel Rayón; Domingo Carras 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Differential transcriptome patterns for

Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation

✍ Tadafumi Asaoka; Tomoaki Kato; Shigeru Marubashi; Keizo Dono; Naoki Hama; Hideno 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

Histopathological evaluation of the liver via biopsy remains the standard procedure for the diagnosis of both acute cellular rejection (ACR) and recurrent hepatitis C (RHC) after liver transplantation. Nevertheless, it is often difficult to diagnose ACR in hepatitis C virus-positive recipients becau

Ribavirin treatment facilitates weaning

Ribavirin treatment facilitates weaning from immunosuppression in liver transplant recipients with recurrent hepatitis C

✍ M. Angelico; R. Lionetti; F. Casarelli; S. Zazza; T. Manzia; D. Di Paolo; A. Pet 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Comparison of tacrolimus with cyclospori

Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation

✍ Z Ben-Ari; E Mor; N Bar-Nathan; E Shaharabani; Z Shapira; R Tur-Kaspa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Impact of tacrolimus versus cyclosporine

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial

✍ Paul Martin; Ronald W. Busuttil; Robert M. Goldstein; Jeffrey S. Crippin; Goran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p

Course of recurrent and acquired hepatit

Course of recurrent and acquired hepatitis C virus infection in liver transplant recipients

✍ G. Dijkstra; E.B. Haagsma; H.T.M. Cuypers; P. Schröder; F. Dijkman; A.S.H. Gouw; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 271 KB